Palo Alto Networks, Inc. (PANW) Is At $153.87 Formed Wedge; Aevi Genomic Medicine (GNMX) Sellers Increased By 5.83% Their Shorts

Aevi Genomic Medicine Incorporated (NASDAQ:GNMX) had an increase of 5.83% in short interest. GNMX’s SI was 299,600 shares in January as released by FINRA. Its up 5.83% from 283,100 shares previously. With 458,600 avg volume, 1 days are for Aevi Genomic Medicine Incorporated (NASDAQ:GNMX)’s short sellers to cover GNMX’s short positions. The SI to Aevi Genomic Medicine Incorporated’s float is 1.3%. The stock increased 1.33% or $0.02 during the last trading session, reaching $1.52. About 274,126 shares traded. Aevi Genomic Medicine, Inc. (NASDAQ:GNMX) has declined 73.36% since January 23, 2017 and is downtrending. It has underperformed by 90.06% the S&P500.

Palo Alto Networks, Inc. (PANW) formed wedge up with $163.10 target or 6.00% above today’s $153.87 share price. Palo Alto Networks, Inc. (PANW) has $14.14 billion valuation. The stock decreased 2.13% or $3.35 during the last trading session, reaching $153.87. About 1.88M shares traded or 31.12% up from the average. Palo Alto Networks, Inc. (NYSE:PANW) has declined 16.31% since January 23, 2017 and is downtrending. It has underperformed by 33.01% the S&P500.

Since September 8, 2017, it had 0 buys, and 11 insider sales for $52.49 million activity. $227,920 worth of stock was sold by Eschenbach Carl M. on Friday, September 8. The insider ZUK NIR sold $4.44 million. MCLAUGHLIN MARK D sold $5.24 million worth of stock. MERESMAN STANLEY J had sold 2,000 shares worth $302,024. Shares for $6.36M were sold by Anderson Mark. BONVANIE RENE sold $4.09 million worth of stock or 27,248 shares.

Among 52 analysts covering Palo Alto Networks (NYSE:PANW), 41 have Buy rating, 2 Sell and 9 Hold. Therefore 79% are positive. Palo Alto Networks has $235 highest and $119 lowest target. $171.23’s average target is 11.28% above currents $153.87 stock price. Palo Alto Networks had 181 analyst reports since July 22, 2015 according to SRatingsIntel. Needham downgraded the shares of PANW in report on Friday, May 27 to “Hold” rating. The firm has “Buy” rating by Needham given on Friday, February 26. Northland Capital initiated Palo Alto Networks, Inc. (NYSE:PANW) on Thursday, January 21 with “Outperform” rating. The stock of Palo Alto Networks, Inc. (NYSE:PANW) earned “Overweight” rating by Morgan Stanley on Tuesday, October 10. The stock of Palo Alto Networks, Inc. (NYSE:PANW) has “Buy” rating given on Friday, May 27 by Wunderlich. As per Friday, September 11, the company rating was maintained by Imperial Capital. The firm earned “Neutral” rating on Friday, October 16 by DA Davidson. Northland Capital maintained it with “Buy” rating and $175.0 target in Friday, September 1 report. The firm has “Buy” rating by Argus Research given on Tuesday, September 5. The firm earned “Outperform” rating on Tuesday, November 24 by Oppenheimer.

Analysts await Palo Alto Networks, Inc. (NYSE:PANW) to report earnings on February, 27. They expect $-0.21 earnings per share, up 63.79% or $0.37 from last year’s $-0.58 per share. After $-0.16 actual earnings per share reported by Palo Alto Networks, Inc. for the previous quarter, Wall Street now forecasts 31.25% negative EPS growth.